IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Lung

The most commonly diagnosed type of lung cancer is carcinoma. There are many types of carcinoma-derived lung cancers, but the significant types are classified as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC and NSCLC are the second cancer leaders. In comparison to NSCLC, SCLC can proliferate and form solid tumor masses more rapidly. In contrast with this highly proliferative potential, SCLC is known to be less aggressive than non-small lung malignancies.

NSCLC is the most prevalent tumor type and is responsible for nearly 85% of lung cancers. The primary tumor types derived from NSCLC are: Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma

Indian Pharma Network

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in
Manage My Orders

Lurbinectedin-solution

Zepzelca 4 Mg Intravenous Solution
Alkylating Agents

Zepzelca (lurbinectedin) is a medication used for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Facts about Lurbinectedin-solution

Disease Indications-Lung Cancer
Manufacturer-Jazz Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “Lurbinectedin-solution” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

mobocertinib capsules

mobocertinib capsules
for oral use Initial U.S. Approval: 2021

EXKIVITY is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

Facts about mobocertinib capsules

Approval Date: 5/13/2021
Proprietary Name: On Request
Active Ingredient(s): mobocertinib capsules
FDA-approved use: non-small cell lung cancer (NSCLC)
Dosage Form:  40 mg
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import mobocertinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

naxitamab-gqgk injection

naxitamab-gqgk injection
for intravenous use Initial U.S. Approval: 2020

Danyelza (naxitamab-gqgk) is a medication used to treat children aged 1 year or older and adults with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow.

Facts about naxitamab-gqgk injection

DISEASE INDICATIONS-Neuroblastoma
MANUFACTURER-Y-mAbs Therapeutics
USAGE-Intravenous
Dosage Forms and Strengths: Injection: 40 mg/10 mL (4 mg/mL) in a single-dose vial.
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “naxitamab-gqgk injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

necitumumab injection

necitumumab injection
for intravenous use Initial U.S. Approval: 2015

Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer. This medicine has been approved in The US, Canda and Europe. We can get you the US FDA approved stock.

Facts about necitumumab injection

DISEASE INDICATIONS-Lung Cancer
MANUFACTURER-Eli Lilly Nederland B.V.
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “necitumumab injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

nintedanib capsules

nintedanib capsules
for oral use Initial U.S. Approval: 2014

OFEV is a kinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

Facts about nintedanib capsules

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s):  nintedanib capsules
Dosage Forms And Strengths: Capsules: 150 mg and 100 mg
Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Current indications: idiopathic pulmonary fibrosis (IPF).
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “nintedanib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

nivolumab injection

, , , ,

nivolumab injection
for intravenous use Initial U.S. Approval: 2014

Nivolumab is used for the treatment of patients with Classic Hodgkin lymphoma, Colorectal cancer, Esophageal cancer or gastroesophageal junction adenocarcinoma, Gastric (stomach) cancer, gastroesophageal junction adenocarcinoma, or esophageal cancer, Malignant pleural mesothelioma, Melanoma, Non-small cell lung cancer, Renal cell carcinoma, Squamous cell carcinoma of the head and neck, Urothelial carcinoma.

Facts about nivolumab injection

Dosage Forms and strengths: Injection: 40 mg/4 mL, 100 mg/10 mL, and 240 mg/24 mL solution in a single dose vial.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “nivolumab injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

ORKAMBI (lumacaftor/ivacaftor) tablets

ORKAMBI (lumacaftor/ivacaftor) tablets

ORKAMBI is a combination of lumacaftor and ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, indicated for the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the F508del mutation on both alleles of the CFTR gene.

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import ORKAMBI (lumacaftor/ivacaftor) tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

osimertinib tablet

osimertinib tablet
for oral use Initial U.S. Approval: 2015

Tagrisso (osimertinib) is a medicine for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with a T790M mutation in the epidermal growth factor receptor (EGFR) gene.

Facts about osimertinib tablet

DISEASE INDICATIONS- non-small cell lung cancer
MANUFACTURER-AstraZeneca AB
USAGE-Oral Tablets: 80 mg and 40 mg
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “osimertinib tablet” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

paclitaxel injection

, ,

paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for intravenous use Initial U.S. Approval: 2005

paclitaxel injection is a prescription medicine used to treat some forms of: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma It is not known if TAXOL is safe or effective in children.

Facts about paclitaxel injection

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): paclitaxel injection
Dosage Forms And Strengths: For injectable suspension: white to yellow, sterile, lyophilized powder containing 100 mg of paclitaxel formulated as albumin-bound particles in single-dose vial for reconstitution.
Current indications: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import paclitaxel injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

PALIVIZUMAB Injection

Palivizumab injection, for intramuscular use Initial U.S. Approval: 1998

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import PALIVIZUMAB Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in 
urgent@indianpharmanetwork.co.in